Stock LIPI LIPIDOR AB
Add to a list
To use this feature you must be a member
Log inSign up

News Lipidor AB

Equities

LIPI

SE0012558617

Delayed Nasdaq Stockholm
Other stock markets
 06:51:06 2024-07-16 EDT 		5-day change 1st Jan Change
0.05 SEK +0.81% Intraday chart for Lipidor AB +6.38% -90.08%
05-22 Lipidor AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-22 Lipidor AB Postpones the Publication of Annual Report for 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lipidor resolves on a directed issue of shares to underwriters in connection with the completion of the rights issue
AQ
Lipidor's rights issue and share capital reduction are registered – conversion of BTU into shares and warrants
AQ
Lipidor announces final outcome in the rights issue
AQ
Lipidor announces preliminary outcome in the rights issue
AQ
Last day of trading in unit rights in Lipidor's rights issue
AQ
Bulletin from the Annual General Meeting of Lipidor AB (publ)
AQ
Lipidor invites to digital presentations with Q&A
AQ
Today the subscription period in Lipidor's rights issue begins
AQ
Lipidor publishes prospectus due to upcoming rights issue of units
AQ
Lipidor AB (publ) publishes interim report for Q1 2024
AQ
Lipidor AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Bulletin from the Extraordinary General Meeting of Lipidor AB (publ)
AQ
Lipidor AB (publ) publishes annual report for 2023
AQ
NOTICE OF ANNUAL GENERAL MEETING IN LIPIDOR AB (PUBL)
AQ
Lipidor AB announces new date for publication of Annual Report 2023
AQ
Lipidor AB Postpones the Publication of Annual Report for 2023
CI
NOTICE OF EXTRAORDINARY GENERAL MEETING IN LIPIDOR AB (PUBL)
AQ
Lipidor resolves on a rights issue of approximately SEK 58.0 million and enters into a co-investment agreement which secures funding for the implementation of the upcoming phase III study
AQ
Lipidor completes planned divestment of shares in Emollivet
AQ
Lipidor announces approval for start of Phase III clinical trial of psoriasis candidate AKP02G2
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LIPI Stock
  4. News Lipidor AB